SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Jul-24 7:30 AM View: | Verve Therapeutics, Inc. (VERV) | 28-Jun-24 | Option Exercise | 30,000 | $2.87 | $86,100.00 | 5% 643.12K to 673.12K | |
05-Oct-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 03-Oct-22 | Option Exercise | 50,000 | $1.39 | $69,500.00 | 8% 639.83K to 689.83K | |
05-Oct-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 03-Oct-22 | Planned Option Sale | 50,000 | $33.65 | $1,682,620.00 | (7%) 689.83K to 639.83K | |
11-Aug-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 10-Aug-22 | Option Exercise | 50,000 | $1.39 | $69,500.00 | 8% 639.83K to 689.83K | |
11-Aug-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 10-Aug-22 | Planned Option Sale | 50,000 | $29.90 | $1,495,000.00 | (7%) 689.83K to 639.83K | |
21-Jul-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 19-Jul-22 | Option Exercise | 50,000 | $1.39 | $69,500.00 | 8% 639.83K to 689.83K | |
21-Jul-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 19-Jul-22 | Planned Option Sale | 50,000 | $29.90 | $1,495,000.00 | (7%) 689.83K to 639.83K | |
15-Jul-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 07-Jul-22 | Gift | 160,000 | -- | -- | 25% 639.83K to 799.83K | |
15-Jul-22 5:00 PM View: | Verve Therapeutics, Inc. (VERV) | 07-Jul-22 | Gift | 160,000 | -- | -- | (20%) 799.83K to 639.83K | |
22-Mar-22 7:41 AM View: | Verve Therapeutics, Inc. (VERV) | 18-Mar-22 | Option Exercise | 69,674 | $2.87 | $199,964.00 | 12% 569.85K to 639.52K | |
06-Jan-22 4:36 PM View: | Verve Therapeutics, Inc. (VERV) | 04-Jan-22 | Option Exercise | 1,870 | $1.39 | $2,599.30 | < 1% 568.53K to 570.4K | |
06-Jan-22 4:36 PM View: | Verve Therapeutics, Inc. (VERV) | 04-Jan-22 | Market Option Sale (Planned) | 1,870 | $39.90 | $74,613.00 | (< 1%) 570.4K to 568.53K | |
29-Dec-21 4:38 PM View: | Verve Therapeutics, Inc. (VERV) | 28-Dec-21 | Option Exercise | 6,693 | $1.39 | $9,303.27 | 1% 568.53K to 575.22K | |
29-Dec-21 4:38 PM View: | Verve Therapeutics, Inc. (VERV) | 28-Dec-21 | Market Option Sale (Planned) | 6,693 | $39.90 | $267,051.00 | (1%) 575.22K to 568.53K | |
29-Dec-21 4:38 PM View: | Verve Therapeutics, Inc. (VERV) | 27-Dec-21 | Option Exercise | 42,000 | $1.39 | $58,380.00 | 7% 568.53K to 610.53K | |
29-Dec-21 4:38 PM View: | Verve Therapeutics, Inc. (VERV) | 27-Dec-21 | Market Option Sale (Planned) | 42,000 | $40.20 | $1,688,480.00 | (7%) 610.53K to 568.53K | |
27-Dec-21 6:08 PM View: | Verve Therapeutics, Inc. (VERV) | 23-Dec-21 | Option Exercise | 57,000 | $1.39 | $79,230.00 | 10% 568.53K to 625.53K | |
27-Dec-21 6:08 PM View: | Verve Therapeutics, Inc. (VERV) | 23-Dec-21 | Market Option Sale (Planned) | 57,000 | $39.90 | $2,274,300.00 | (9%) 625.53K to 568.53K | |
27-Dec-21 6:08 PM View: | Verve Therapeutics, Inc. (VERV) | 22-Dec-21 | Option Exercise | 57,000 | $1.39 | $79,230.00 | 10% 568.53K to 625.53K | |
27-Dec-21 6:08 PM View: | Verve Therapeutics, Inc. (VERV) | 22-Dec-21 | Market Option Sale (Planned) | 57,000 | $38.71 | $2,206,300.00 | (9%) 625.53K to 568.53K | |
21-Jun-21 6:20 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Private Purchase | 2,500 | $19.00 | $47,500.00 | < 1% 566.03K to 568.53K |